Biopico Systems Inc.
Irvine, CA
- UEI
- MU14LUW1RH41
- CAGE
- 4T0R3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325199 All Other Basic Organic Chemical Manufacturing
- 326199 All Other Plastics Product Manufacturing
- 333914 Measuring, Dispensing, and Other Pumping Equipment Manufacturing
- 334111 Electronic Computer Manufacturing
- 334513 Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
- 334514 Totalizing Fluid Meter and Counting Device Manufacturing
- 334515 Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration date
- Physical address
- 188 Technology Dr Ste G, Irvine, CA 92618, USA
- Website
- biopico.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $249,998 |
| FY2025 | -$17,000 |
| FY2024 | $166,499 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | National Aeronautics and Space Administration | $249,998 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mimetas US Inc. | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Neucyte Inc. | Mountain View, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Hesperos, Inc. | Orlando, FL | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Lena Biosciences, Inc. | Atlanta, GA | — |
| Vala Sciences Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Biopico Systems Inc., located in Irvine, California, is a minority-owned, for-profit corporate entity specializing in advanced biomedical research and development of innovative organ-on-chip technologies. Registered in SAM.gov since 2007, the company focuses on developing sophisticated in vitro models and platforms for pharmaceutical research, drug discovery, and medical screening applications. The company appears to concentrate on creating high-throughput, multiorgans systems that can simulate complex biological interactions for research purposes, with a particular emphasis on developing advanced screening technologies for neurological and cellular research.
Regarding federal contract awards, Biopico Systems Inc. has been awarded a $166,499 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract from NASA. This specific contract is for developing a "Platform for Radiation-Induced Senescence using Multiorgans (PRISM) for High Throughput Senolytics Screening," which supports NASA's research initiatives. The contract was set aside for small businesses and has a performance period through February 6, 2025. The contract type is a purchase order, indicating a focused, specific research development project within NASA's innovation ecosystem.
In terms of federal grant awards, Biopico Systems Inc. has received multiple significant grants from different National Institutes of Health (NIH) divisions. These grants include a grant from the National Institute on Aging (R43AG073040) for developing a "Humanized Organ Plate Paradigm for High Throughput Alzheimer's Disease Therapeutics," a grant from the National Institute of General Medical Sciences (R44GM139413) for creating a cGMP compliant closed cell culture system for de-differentiating human somatic cells into iPSCs, and a grant from the National Institute of Environmental Health Sciences (R43ES032357) for developing a Fluidic Programmable Gravi-Maze Array for multi-organ drug testing. These grants demonstrate the company's expertise in developing advanced cellular research platforms, with a strong focus on neurological disease research, cellular transformation techniques, and innovative drug screening methodologies.
SBA capabilities narrative
R&D in microfluidics, electrical sensing, cell based assays, electronics instrumentation
Quick answers
Is Biopico Systems Inc. registered in SAM.gov?
Yes. Biopico Systems Inc.'s SAM.gov registration is active through August 3, 2027.
How much has Biopico Systems Inc. received in federal contracts?
Federal contracts obligated $399,497 to Biopico Systems Inc. in fiscal years 2023 through 2027.
What is Biopico Systems Inc.'s most recent federal award?
Biopico Systems Inc.'s most recent federal contract award is This project will develop the prism cmevaluate human multiorgan micro-physiological platform to assess… (80NSSC26P0952), from Shared Services Center, on July 7, 2026.
On GovTribe
See Biopico Systems Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors